SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,902.59 138.36
( 0.19%)

Global Indices

Nasdaq

52,403.42 -403.65
(-0.76%)

Dow Jones

7,657.83 -36.69
(-0.48%)

Hang Seng

65,056.24 -86.54
(-0.13%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.74 0.23
(0.24%)

EUR-INR

110.11 0.28
(0.26%)

GBP-INR

128.27 0.39
(0.30%)

JPY-INR

0.62 0.01
(0.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Va Tech Wabag Ltd

Industry : Engineering - Turnkey Services

BSE Code

ISIN Demat

Book Value()

533269

INE956G01038

337.3412416

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WABAG

37.38

13319.14

EPS(TTM)

Face Value()

Div & Yield %

57.02

0.23

Back

gl& pharma ltd

Gland Pharma consolidated net profit rises 47.09% in the June 2026 quarter

Aug 10,2026

Net profit of Gland Pharma rose 47.09% to Rs 316.96 crore in the quarter ended June 2026 as against Rs 215.48 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 1800.27 crore in the quarter ended June 2026 as against Rs 1505.62 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1800.27	1505.62	20
OPM %	27.18	24.43	-
PBDT	546.23	413.79	32
PBT	434.98	312.74	39
NP	316.96	215.48	47

74,902.59 138.36 ( 0.19%)

52,403.42 -403.65 (-0.76%)

7,657.83 -36.69 (-0.48%)

65,056.24 -86.54 (-0.13%)

10,664.98 -146.68 (-1.36%)

94.74 0.23 (0.24%)

110.11 0.28 (0.26%)

128.27 0.39 (0.30%)

0.62 0.01 (0.94%)